You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
美諾華:為進一步推進鹽酸阿比多爾原料藥的聯合研發和生產進度 與先聲製藥簽訂正式項目合作協議書
格隆匯 02-10 19:35

格隆匯2月10日丨美諾華(603538.SH)公佈,誠如之前公告披露,公司控股子公司宣城美諾華藥業有限公司(“宣城美諾華”)與南京先聲東元製藥有限公司(“先聲製藥”)合作,共同研發抗病毒領域原料藥鹽酸阿比多爾及其他多種抗病毒原料藥。該事項尚需提交股東大會審議批准。

為了進一步推進鹽酸阿比多爾原料藥的聯合研發和生產進度,宣城美諾華與先聲製藥於2020年2月10日簽訂了正式的《項目合作協議書》。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account